These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2850928)
1. Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens. Verlinde C; De Ranter C Eur J Pharmacol; 1988 Aug; 153(1):83-7. PubMed ID: 2850928 [TBL] [Abstract][Full Text] [Related]
2. Profile of activity of kappa receptor agonists in the rabbit vas deferens. Hayes A; Kelly A Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982 [TBL] [Abstract][Full Text] [Related]
3. A novel series of potent and selective agonists at the opioid kappa-receptor. Costello GF; Main BG; Barlow JJ; Carroll JA; Shaw JS Eur J Pharmacol; 1988 Jul; 151(3):475-8. PubMed ID: 2850924 [TBL] [Abstract][Full Text] [Related]
4. Bremazocine: a potent, long-acting opiate kappa-agonist. Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759 [No Abstract] [Full Text] [Related]
5. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists. Martín MI; Alfaro MJ; Goicoechea C; Colado MI Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807 [TBL] [Abstract][Full Text] [Related]
6. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359 [TBL] [Abstract][Full Text] [Related]
7. Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests. Gillan MG; Kosterlitz HW; Magnan J Br J Pharmacol; 1981 Jan; 72(1):13-5. PubMed ID: 6261863 [TBL] [Abstract][Full Text] [Related]
8. The opioid receptors in the hamster vas deferens are of the delta-type. McKnight AT; Corbett AD; Marcoli M; Kosterlitz HW Neuropharmacology; 1985 Nov; 24(11):1011-7. PubMed ID: 3001569 [TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. Kajiwara M; Aoki K; Ishii K; Numata H; Matsumiya T; Oka T Jpn J Pharmacol; 1986 Jan; 40(1):95-101. PubMed ID: 3007830 [TBL] [Abstract][Full Text] [Related]
10. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus. Corbett AD; Kosterlitz HW Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544 [TBL] [Abstract][Full Text] [Related]
11. Opioid activity of a benzomorphan lacking an oxygen atom. Goldstein A; Naidu A Biochem Pharmacol; 1978 Apr; 27(7):1033-6. PubMed ID: 207286 [No Abstract] [Full Text] [Related]
12. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors. Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
14. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488. Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566 [TBL] [Abstract][Full Text] [Related]
15. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum. Traynor JR; Corbett AD; Kosterlitz HW Eur J Pharmacol; 1987 May; 137(1):85-9. PubMed ID: 3038579 [TBL] [Abstract][Full Text] [Related]
16. Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum. Goodall J; Hughes IE; Mackay D Br J Pharmacol; 1985 May; 85(1):277-83. PubMed ID: 2992651 [TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist opioid activity of axial and equatorial conformations of S-methyl- and S-allyl-morphinans. Lemaire S; Belleau B; Jolicoeur FB Eur J Pharmacol; 1994 Jun; 258(1-2):111-8. PubMed ID: 7925589 [TBL] [Abstract][Full Text] [Related]
18. The choice of opiate receptor subtype by neo-endorphins. Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522 [TBL] [Abstract][Full Text] [Related]
19. A series of novel, highly potent and selective agonists for the kappa-opioid receptor. Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823 [TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. Picker MJ; Dykstra LA J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]